Kevin Marsh

B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area.Dorfman JR, Bejon P, Ndungu FM, Langhorne J, Kortok MM, Lowe BS, Mwangi TW, Williams TN, Marsh K
J Infect Dis, (2005). 191:1623-30

Genomewide analysis of the host response to malaria in Kenyan children.Griffiths MJ, Shafi MJ, Popper SJ, Hemingway CA, Kortok MM, Wathen A, Rockett KA, Mott R, Levin M, Newton CR, Marsh K, Relman DA, Kwiatkowski DP
J Infect Dis, (2005). 191:1599-611

Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study.Berkley JA, Maitland K, Mwangi I, Ngetsa C, Mwarumba S, Lowe BS, Newton CR, Marsh K, Scott JA, English M
BMJ, (2005). 330:995

Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?.Nzila A, Ochong E, Nduati E, Gilbert K, Winstanley P, Ward S, Marsh K
Trans R Soc Trop Med Hyg, (2005). 99:341-6

Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit.Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton C, Levin M
Clin Infect Dis, (2005). 40:538-45

Volume status in severe malaria: no evidence provided for the degree of filling of the intravascular compartment.Maitland K, Newton C, Marsh K, Levin M
PLoS Med, (2005). 2:e27; author reply e32

Pre-transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion.Maitland K, Pamba A, English M, Peshu N, Levin M, Marsh K, Newton CR
Br J Haematol, (2005). 128:393-400

Bacteremia among children admitted to a rural hospital in Kenya.Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, Ngetsa C, Slack MP, Njenga S, Hart CA, Maitland K, English M, Marsh K, Scott JA
N Engl J Med, (2005). 352:39-47

Antibodies to voltage-gated calcium channels in children with falciparum malaria.Lang B, Newbold CI, Williams G, Peshu N, Marsh K, Newton CR
J Infect Dis, (2005). 191:117-21

Therapeutic potential of folate uptake inhibition in Plasmodium falciparum.Nzila AM, Kokwaro G, Winstanley PA, Marsh K, Ward SA
Trends Parasitol, (2004). 20:109-12

Malaria and nutritional status in children living on the coast of Kenya.Nyakeriga AM, Troye-Blomberg M, Chemtai AK, Marsh K, Williams TN
Am J Clin Nutr, (2004). 80:1604-10

Mortality among Kenyan children admitted to a rural district hospital on weekends as compared with weekdays.Berkley JA, Brent A, Mwangi I, English M, Maitland K, Marsh K, Peshu N, Newton CR
Pediatrics, (2004). 114:1737-8; author reply 1738

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.Polley SD, Mwangi T, Kocken CH, Thomas AW, Dutta S, Lanar DE, Remarque E, Ross A, Williams TN, Mwambingu G, Lowe B, Conway DJ, Marsh K
Vaccine, (2004). 23:718-28

Clinical features and pathogenesis of severe malaria.Mackintosh CL, Beeson JG, Marsh K
Trends Parasitol, (2004). 20:597-603

Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P, Jensen AT, Lavstsen T, Ofori MF, Marsh K, Hviid L, Theander TG
J Exp Med, (2004). 200:1197-203

Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K
J Infect Dis, (2004). 190:1527-33

Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast.Molyneux CS, Peshu N, Marsh K
Soc Sci Med, (2004). 59:2547-59

Bayesian age-stage modelling of Plasmodium falciparum sequestered parasite loads in severe malaria patients.Smith T, Dietz K, Vounatsou P, Muller I, English M, Marsh K
Parasitology, (2004). 129:289-99

In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.Ommeh S, Nduati E, Mberu E, Kokwaro G, Marsh K, Rosowsky A, Nzila A
Antimicrob Agents Chemother, (2004). 48:3711-4

Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.Staalsoe T, Shulman CE, Dorman EK, Kawuondo K, Marsh K, Hviid L
Infect Immun, (2004). 72:5027-30